Scilex Holding Co (SCLX)
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
$5.42+2.65%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
QuarterlyIQ Insights · SCLX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 31.6 | 30.3 | 56.6 | 46.7 | 38.0 | 31.3 | 23.6 |
| Total Revenues | 31.6 | 30.3 | 56.6 | 46.7 | 38.0 | 31.3 | 23.6 |
| Cost of Revenues | — | 96.3 | 16.7 | 15.7 | 10.8 | 3.6 | 2.1 |
| Gross Profit | — | 125.8 | — | — | — | — | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 278.0 | 266.9 | 119.0 | 119.6 | 64.9 | 50.6 | 43.0 |
| R&D Expenses | 18.6 | 20.7 | 9.6 | 12.7 | 9.1 | 9.2 | 10.0 |
| Other Operating Expenses, Total | — | — | — | — | — | 1.8 | — |
| Operating Income | (359.2) | (346.0) | (83.4) | (105.4) | (50.6) | (35.8) | (35.3) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 11.5 | 2.0 | 1.1 | 9.6 | 11.8 | 13.1 |
| Other Non-Operating Income / Expenses | (105.4) | (28.0) | 10.6 | (8.9) | 27.3 | (52.6) | (12.3) |
| EBT, Incl. Unusual Items | (464.5) | (374.0) | (72.8) | (114.3) | (23.4) | (88.4) | (47.6) |
| Income Tax Expense | — | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 | (0.1) |
| Net Income | |||||||
| Minority Interest | — | 11.8 | — | — | — | — | — |
| Net Income | (464.6) | (374.1) | (72.8) | (114.3) | (23.4) | (88.4) | (47.5) |
| Per Share | |||||||
| Basic EPS | (67.41) | (36.48) | (0.56) | (1.28) | (0.17) | (0.67) | (0.36) |
| Diluted EPS | (67.41) | (36.48) | (0.61) | (1.28) | (0.17) | (0.67) | (0.36) |
| Revenue per Share | 4.59 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 6.9 | 0.0 | 131.1 | 130.3 | 134.2 | 132.9 | 0.1 |
| Diluted Weighted Avg Shares | 6.9 | 0.0 | 134.1 | 130.3 | 134.2 | 132.9 | 0.1 |
| Supplemental | |||||||
| EBITDA | — | (341.4) | (79.4) | (101.3) | (46.7) | (32.1) | (31.5) |
| EBIT | (359.2) | (346.0) | (83.4) | (105.4) | (50.6) | (35.8) | (35.3) |
| Effective Tax Rate | — | — | — | -0.0% | -0.0% | -0.0% | 0.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.